Skip to Main Content

Illumina Inc

ILMN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

$ILMN is featured in our U.S. House Long-Short strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
ILMN Income Statement
ILMN Balance Sheet
ILMN Cash Flow

Recent trades of ILMN by members of U.S. Congress

Politician Type Traded
Michael C. Burgess House / R Sale $15,001 - $50,000 Sep. 03, 2024
Michael C. Burgess House / R Sale $15,001 - $50,000 Aug. 30, 2024
Thomas H. Kean, Jr. House / R Purchase $1,001 - $15,000 Apr. 19, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Jan. 02, 2024
Michael C. Burgess House / R Purchase $1,001 - $15,000 Jan. 02, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Jan. 02, 2024
Kathy E. Manning House / D Sale $15,001 - $50,000 Jun. 10, 2022
Donald S. Beyer, Jr. House / D Sale $15,001 - $50,000 Feb. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Dec. 01, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Oct. 26, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Sep. 17, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Aug. 25, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 06, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 Feb. 24, 2021
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 17, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov. 06, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Aug. 27, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul. 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 01, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Apr. 27, 2020
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Mar. 11, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Feb. 14, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 10, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 23, 2019
John B. Larson House / D Sale $1,001 - $15,000 Dec. 18, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 10, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 25, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 19, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 11, 2019
Susan A. Davis House / D Purchase $15,001 - $50,000 Jan. 11, 2019
Sheldon Whitehouse Senate / D Purchase $1,001 - $15,000 Dec. 28, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 24, 2018
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 24, 2017
K. Michael Conaway House / R Purchase $1,001 - $15,000 Feb. 09, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
ILMN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ILMN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ILMN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ILMN's directors and management

Government lobbying spending instances

  • $280,000 Dec 12, 2024 Issue: Budget/Appropriations Defense Health Issues
  • $270,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $380,000 Apr 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $510,000 Jan 22, 2024 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $420,000 Oct 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $1,460,000 Jul 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $50,000 May 04, 2023 Issue: Trade (domestic/foreign)
  • $1,300,000 Jan 20, 2023 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,380,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,690,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,960,000 Apr 20, 2022 Issue: Government Issues Health Issues
  • $820,000 Jan 20, 2022 Issue: Government Issues
  • $10,000 Jan 20, 2022 Issue: Government Issues
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: None
  • $40,000 Jan 20, 2022 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $60,000 Jan 19, 2022 Issue: Health Issues
  • $320,000 Jan 19, 2022 Issue: Health Issues Government Issues
  • $10,000 Oct 28, 2021 Issue: Government Issues
  • $920,000 Oct 21, 2021 Issue: Government Issues
  • $60,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: None
  • $40,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $10,000 Oct 19, 2021 Issue: Government Issues
  • $50,000 Oct 19, 2021 Issue: Health Issues
  • $375,000 Oct 18, 2021 Issue: Health Issues Government Issues
  • $20,000 Jul 29, 2021 Issue: Health Issues
  • $60,000 Jul 20, 2021 Issue: Health Issues Labor Issues/Antitrust/Workplace
  • $40,000 Jul 20, 2021 Issue: Labor Issues/Antitrust/Workplace Health Issues Veterans Medicare/Medicaid
  • $40,000 Jul 20, 2021 Issue: Government Issues
  • $150,000 Jul 19, 2021 Issue: Health Issues Government Issues
  • $50,000 Jul 19, 2021 Issue: Trade (domestic/foreign)
  • $290,000 Apr 20, 2021 Issue: None
  • $270,000 Jan 21, 2021 Issue: None
  • $270,000 Oct 20, 2020 Issue: None
  • $170,000 Jul 20, 2020 Issue: None
  • $180,000 Apr 20, 2020 Issue: HEALTH ISSUES
  • $190,000 Jan 21, 2020 Issue: None
  • $160,000 Oct 21, 2019 Issue: Budget/Appropriations Health Issues
  • $160,000 Jul 22, 2019 Issue: Budget/Appropriations Health Issues
  • $130,000 Apr 22, 2019 Issue: Health Issues Budget/Appropriations
  • $60,000 Jan 22, 2019 Issue: Health Issues
  • $60,000 Oct 22, 2018 Issue: Health Issues
  • $70,000 Jul 20, 2018 Issue: Health Issues
  • $100,000 Apr 20, 2018 Issue: Medicare/Medicaid Budget/Appropriations
  • $50,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid
  • $40,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $45,000 Jan 13, 2017 Issue: Health Issues
  • $45,000 Oct 19, 2016 Issue: Health Issues
  • $60,000 Jul 20, 2016 Issue: Health Issues
  • $90,000 Apr 20, 2016 Issue: Health Issues
  • $20,000 Jan 20, 2016 Issue: Health Issues
  • $40,000 Jan 18, 2013 Issue: Homeland Security Science/Technology Defense

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Reagent cartridge Jan. 25, 2022
  • Patent Title: Reagent cartridge Jan. 25, 2022
  • Patent Title: Dual optical grating slide structured illumination imaging Jan. 18, 2022
  • Patent Title: Display screen with a graphical user interface Jan. 11, 2022
  • Patent Title: Calcium carbonate slurry Jan. 04, 2022
  • Patent Title: Imprinting apparatus Jan. 04, 2022
  • Patent Title: Artificial intelligence-based generation of sequencing metadata Dec. 28, 2021
  • Patent Title: Digital microfluidic system for single-cell isolation and characterization of analytes Dec. 21, 2021
  • Patent Title: Modified polymerases for improved incorporation of nucleotide analogues Dec. 14, 2021
  • Patent Title: Liquid storage and delivery mechanisms and methods Dec. 07, 2021
  • Patent Title: Reagent channel mixing system and method Dec. 07, 2021
  • Patent Title: Flow cells with chambers, depressions, and capture sites Dec. 07, 2021
  • Patent Title: Systems and methods for improved focus tracking using a hybrid mode light source Nov. 30, 2021
  • Patent Title: Equalization-based image processing and spatial crosstalk attenuator Nov. 30, 2021
  • Patent Title: Biosensors for biological or chemical analysis and methods of manufacturing the same Nov. 23, 2021
  • Patent Title: Dna sequencing using hydrogel beads Nov. 23, 2021
  • Patent Title: Liquid sample loading Nov. 23, 2021
  • Patent Title: System and method for large sample analysis of thin film Nov. 16, 2021
  • Patent Title: Disposable, integrated microfluidic cartridge and methods of making and using same Nov. 16, 2021
  • Patent Title: Gel patterned surfaces Nov. 16, 2021
  • Patent Title: Enclosures and corresponding magnetic joints Oct. 26, 2021
  • Patent Title: Orthogonal deblocking of nucleotides Oct. 26, 2021
  • Patent Title: Reduced dimensionality structured illumination microscopy with patterned arrays of nanowells Oct. 19, 2021
  • Patent Title: Phasing correction Oct. 19, 2021
  • Patent Title: Preserving genomic connectivity information in fragmented genomic dna samples Oct. 19, 2021
  • Patent Title: Systems and methods for improved focus tracking using a light source configuration Oct. 12, 2021
  • Patent Title: Flow cell with one or more barrier features Oct. 12, 2021
  • Patent Title: Method for selecting and amplifying polynucleotides Oct. 12, 2021
  • Patent Title: Obtaining information from a biological sample in a flow cell Oct. 05, 2021
  • Patent Title: Display screen or portion thereof with graphical user interface Oct. 05, 2021
  • Patent Title: Systems and methods for improved focus tracking using blocking structures Sep. 21, 2021
  • Patent Title: Biosensors for biological or chemical analysis and methods of manufacturing the same Sep. 21, 2021
  • Patent Title: Flow cells Sep. 21, 2021
  • Patent Title: Inertial droplet generation and particle encapsulation Sep. 21, 2021
  • Patent Title: Predicting structured illumination parameters Sep. 14, 2021
  • Patent Title: Transposon end compositions and methods for modifying nucleic acids Sep. 14, 2021
  • Patent Title: Systems, methods, and apparatuses to image a sample for biological or chemical analysis Sep. 14, 2021
  • Patent Title: Reduced dimensionality structured illumination microscopy with patterned arrays of nanowells Sep. 07, 2021
  • Patent Title: Substrates comprising nano-patterning surfaces and methods of preparing thereof Sep. 07, 2021
  • Patent Title: Multilayer fluidic devices and methods for their fabrication Sep. 07, 2021
  • Patent Title: Polymerases, compositions, and methods of use Aug. 31, 2021
  • Patent Title: Gene expression panel for prognosis of prostate cancer recurrence Aug. 24, 2021
  • Patent Title: Library preparation of tagged nucleic acid Aug. 10, 2021
  • Patent Title: Modulating polymer beads for dna processing Aug. 10, 2021
  • Patent Title: Biosensors for biological or chemical analysis and systems and methods for same Aug. 03, 2021
  • Patent Title: Light visor for sequencing instrument Jul. 20, 2021
  • Patent Title: Microarray fabrication system and method Jul. 13, 2021
  • Patent Title: Predictive focus tracking apparatus and methods Jul. 06, 2021
  • Patent Title: Bioinformatics systems, apparatuses, and methods for generating a de brujin graph Jun. 29, 2021
  • Patent Title: Compositions and methods for polynucleotide sequencing Jun. 22, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of ILMN in WallStreetBets Daily Discussion

ILMN News

Recent insights relating to ILMN

CNBC Recommendations

Recent picks made for ILMN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ILMN

ILMN Top Shareholders
Shareholder
Shares Held
ILMN Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ILMN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ILMN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top